Atlas Trials

Biomarkers in Clozapine-responding Schizophrenia

Clinical trial NCT05316883 · RECRUITING

Trial details

NCT number
NCT05316883
Sponsor
Jimmi Nielsen
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaPsychosis
Start date
2021-02-28
Primary completion
2029-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.